PaulSeligmanMD

Oncology • Aurora, CO

Professor of Medicine, University Colorado

Join to view full profile

Dr. Seligman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Seligman's full profile

Already have an account?

Office
12605 E 16th Ave
Aurora, CO 80045
Phone+1 720-848-0000
Is this information wrong?

Education & Training

University of ColoradoFellowship, Hematology and Medical Oncology, 1978 - 1979
Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 1975 - 1976
University at BuffaloResidency, Internal Medicine, 1973 - 1975
University at BuffaloInternship, Internal Medicine, 1972 - 1973
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 1972

Certifications & Licensure

CO State Medical License 1978 - 2023
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Elected Member The American Society for Clinical Investigation, 1984

Publications & Presentations

PubMed

2 citations
Blockage of the Na-K-ATPase signaling-mediated oxidant amplification loop elongates red blood cell half-life and ameliorates uremic anemia induced by 5/6th PNx in C57B...
Jiang Liu, Muhammad Chaudhry, Fang Bai, Justin Chuang, Hibba Chaudhry, Ala-Eddin Yassin Al-Astal, Ying Nie, Vincent Sollars, Komal Sodhi, Paul Seligman, Joseph I Shapiro> ;American Journal of Physiology. Renal Physiology. 2022 Jun 1
16 citations
Low ferroportin expression in AML is correlated with good risk cytogenetics, improved outcomes and increased sensitivity to chemotherapy.
Maura Gasparetto, Shanshan Pei, Mohammad Minhajuddin, Brett M. Stevens, Clayton A. Smith, Paul Seligman> ;Leukemia Research. 2019 Feb 28
8 citations
The late‐annotated small ORF LSO1 is a target gene of the iron regulon of Saccharomyces cerevisiae
Xiuxiang An, Caiguo Zhang, Robert A. Sclafani, Paul A. Seligman, Mingxia Huang> ;Microbiologyopen. 2015 Dec 1
17 citations
Iron depletion results in Src kinase inhibition with associated cell cycle arrest in neuroblastoma cells
Gamini Siriwardana, Paul A. Seligman> ;Physiological Reports. 2015 Mar 1
20 citations
Two cell cycle blocks caused by iron chelation of neuroblastoma cells: separating cell cycle events associated with each block
Gamini Siriwardana, Paul A. Seligman> ;Physiological Reports. 2013 Dec 1
Development of a teaching module for quality-of-life assessment of terminal patients. The AACE Multi-Institutional Palliative Cancer Education Section. American Associ...
Seligman Pa, Dignon C, Douglas D. Ross, Steen Pd, Janet L. Abrahm, P H Boston, Ferris F, John F. Foley, Paula Nelson-Marten, O'Mara Am, von Gunten Cf, David E. Weissman> ;Journal of Cancer Education. 2009 Oct 1
4 citations
Single-Dosage Pharmacokinetics of Sodium Ferric Gluconate Complex in Iron-Deficient Pediatric Hemodialysis Patients
Bradley A. Warady, Paul A. Seligman, Naomi V. Dahl> ;Clinical Journal of the American Society of Nephrology. 2007 Nov 1
1 citations
A woman with primary breast cancer and a solitary sternal metastasis.
Alexander Menter, Alexander Urquhart, Virginia F. Borges, Rachel Rabinovitch, Meenakshi Singh, William R. Robinson, Paul A. Seligman, Christina Finlayson, Anthony D. E...> ;Oncology. 2006 Aug 1
7 citations
Expression of vascular endothelial growth factor and proliferation marker MIB1 are influenced by neoadjuvant chemotherapy in locally advanced breast cancer.
Meenakshi Singh, Kelly E Capocelli, Jeni L Marks, Rhoda B. Schleicher, Christina Finlayson, Paul A. Seligman> ;Applied Immunohistochemistry & Molecular Morphology. 2005 Jun 1
A postmenopausal woman with early-stage breast cancer and borderline hormone-receptor staining.
Alexander Urquhart, Virginia F. Borges, Rachel Rabinovitch, Meenakshi Singh, William R. Robinson, Paul A. Seligman, Jyoti Arya, Christina Finlayson, Anthony D. Elias> ;Oncology. 2005 Mar 1
30 citations
Single-dose pharmacokinetics of sodium ferric gluconate complex in iron-deficient subjects.
Paul A. Seligman, Naomi V. Dahl, Jur Strobos, Hui C Kimko, Rhoda B. Schleicher, Michael A Jones, Murray P. Ducharme> ;Pharmacotherapy. 2004 May 1
34 citations
Clinical evaluation of heme iron polypeptide: sustaining a response to rHuEPO in hemodialysis patients.
Allen R. Nissenson, Jeffrey S. Berns, Paul G. Sakiewicz, Sana Ghaddar, Gary M Moore, Rhoda B. Schleicher, Paul A. Seligman> ;American Journal of Kidney Diseases. 2003 Aug 1
Palliative Care Section.
Paul A. Seligman, Douglas D. Ross> ;Journal of Cancer Education. 2002 Jan 1
33 citations
Comparison of Methods Used to Measure Serum Iron in the Presence of Iron Gluconate or Iron Dextran
Paul A. Seligman, Rhoda B. Schleicher> ;Clinical Chemistry. 1999 Jun 1
79 citations
Sodium ferric gluconate complex in sucrose is safe and effective in hemodialysis patients: North American Clinical Trial.
Allen R. Nissenson, Robert M. Lindsay, Suzanne K. Swan, Paul A. Seligman, Jur Strobos> ;American Journal of Kidney Diseases. 1999 Mar 1
1 citations
Palliative care education--can we respond to the challenge?
Paul A. Seligman, Douglas D. Ross> ;Journal of Cancer Education. 1999 Jan 1
11 citations
Practicing physicians' assessments of the impact of their medical-school clinical hospice experience.
Paul A. Seligman, Massey E, Fink Rs, Paula Nelson-Marten, von Lobkowitz P> ;Journal of Cancer Education. 1999 Jan 1
87 citations
Measurement of soluble transferrin receptor in serum of healthy adults
Jean Allen, Kristin R. Backstrom, Jeffrey A. Cooper, MaryAnne C. Cooper, Thomas C. Detwiler, David W. Essex, Rose P. Fritz, Robert T. Means, Peter B. Meier, Samuel R. ...> ;Clinical Chemistry. 1998 Jan 1
113 citations
Neuroblastoma Sensitivity to Growth Inhibition by Deferrioxamine: Evidence for a Block in G1 Phase of the Cell Cycle
Chaya Brodie, Gamini Siriwardana, Joseph Lucas, Rhoda B. Schleicher, Nao Terada, Agota Szepesi, Erwin W. Gelfand, Paul A. Seligman> ;Cancer Research. 1993 Sep 1
33 citations
Effects of agents that inhibit cellular iron incorporation on bladder cancer cell proliferation
Paul A. Seligman, Rhoda B. Schleicher, Gamini Siriwardana, Joanne Domenico, Erwin W. Gelfand> ;Blood. 1993 Sep 1
29 citations
Treatment with gallium nitrate: Evidence for interference with iron metabolism in vivo
Paul A. Seligman, Moran Pl, Schleicher Rb, Crawford Ed> ;American Journal of Hematology. 1992 Dec 1
47 citations
Lymphocyte proliferation is controlled by both iron availability and regulation of iron uptake pathways.
Paul A. Seligman, Jan Kovar, Erwin W. Gelfand> ;Pathobiology. 1992 Jan 1
Treatment of advanced transitional cell carcinoma of the bladder with continuous-infusion gallium nitrate.
Seligman, P. A.,Crawford, E. D.> ;J. Natl. Cancer Inst.. 1991 Nov 06
38 citations
Transferrin-independent iron uptake supports B lymphocyte growth.
Paul A. Seligman, Jan Kovar, Rhoda B. Schleicher, Erwin W. Gelfand> ;Blood. 1991 Sep 15
5 citations
Imaging of Non-Small Cell Lung Cancers with a Monoclonal Antibody, KC-4G3, Which Recognizes a Human Milk Fat Globule Antigen
David G. Dienhart, Raymond F. Schmelter, James L. Lear, Gary J. Miller, Stephan D. Glenn, Duane C. Bloedow, Ravindra Kasliwal, Patrick L. Moran, Paul A. Seligman, Jame...> ;Cancer Research. 1990 Nov 1
Join now to see all

Press Mentions

Medication Guides for Certain Prescription ProductsJanuary 3rd, 2010